The feasibility and reliability of transient elastography using Fibroscan® : A practice audit of 2335 examinations

被引:44
作者
Pang, Jack X. Q. [1 ,2 ]
Pradhan, Faruq [1 ]
Zimmer, Scott [3 ]
Niu, Sophia [3 ]
Crotty, Pam [1 ]
Tracey, Jenna [1 ]
Schneider, Christopher [1 ]
Heitman, Steven J. [1 ,2 ]
Kaplan, Gilaad G. [1 ,2 ]
Swain, Mark G. [1 ]
Myers, Robert P. [1 ,2 ]
机构
[1] Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Liver Unit, Calgary, AB T2N 4Z6, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada
[3] Alberta Hlth Serv, Med Serv, Calgary, AB, Canada
关键词
Biopsy; Diagnostic test; Fibrosis; Hepatitis; Stiffness; LIVER STIFFNESS MEASUREMENT; CODING ALGORITHMS; RISK-FACTORS; HEPATITIS-C; FIBROSIS; BIOPSY; COMPLICATIONS; PERFORMANCE; OUTCOMES; COMORBIDITIES;
D O I
10.1155/2014/952684
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Liver stiffness measurement (LSM) using transient elastography is widely used in the management of patients with chronic liver disease. objectives: To examine the feasibility and reliability of LSM, and to identify patient and operator characteristics predictive of poorly reliable results. METHODS: The present retrospective study investigated the frequency and determinants of poorly reliable LSM (interquartile range [IQR]/median LSM [IQR/M] > 30% with median liver stiffness >= 7.1 kPa) using the FibroScan (Echosens, France) over a three-year period. Two experienced operators performed all LSMs. Multiple logistic regression analyses examined potential predictors of poorly reliable LSMs including age, sex, liver disease, the operator, operator experience (< 500 versus >= 500 scans), FibroScan probe (M versus XL), comorbidities and liver stiffness. In a subset of patients, medical records were reviewed to identify obesity (body mass index >= 30 kg/m(2)). RESULTS: Between July 2008 and June 2011, 2335 patients with liver disease underwent LSM (86% using the M probe). LSM failure (no valid measurements) occurred in 1.6% (n=37) and was more common using the XL than the M probe (3.4% versus 1.3%; P=0.01). Excluding LSM failures, poorly reliable LSMs were observed in 4.9% (n=113) of patients. Independent predictors of poorly reliable LSM included older age (OR 1.03 [95% CI 1.01 to 1.05]), chronic pulmonary disease (OR 1.58 [95% CI 1.05 to 2.37), coagulopathy (OR 2.22 [95% CI 1.31 to 3.76) and higher liver stiffness (OR per kPa 1.03 [95% CI 1.02 to 1.05]), including presumed cirrhosis (stiffness >= 12.5 kPa; OR 5.24 [95% CI 3.49 to 7.89]). Sex, diabetes, the underlying liver disease and FibroScan probe were not significant. Although reliability varied according to operator (P < 0.0005), operator experience was not significant. In a subanalysis including 434 patients with body mass index data, obesity influenced the rate of poorly reliable results (OR 2.93 [95% CI 0.95 to 9.05]; P=0.06). CONCLUSIONS: FibroScan failure and poorly reliable LSM are uncommon. The most important determinants of poorly reliable results are older age, obesity, higher liver stiffness and the operator, the latter emphasizing the need for adequate training.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 42 条
[1]  
[Anonymous], 1996, ICES PRACTICE ATLAS, P339
[2]  
[Anonymous], 2003, DAT DISCL HDB, P1
[3]   Determination of reliability criteria for liver stiffness evaluation by transient elastography [J].
Boursier, Jerome ;
Zarski, Jean-Pierre ;
de Ledinghen, Victor ;
Rousselet, Marie-Christine ;
Sturm, Nathalie ;
Lebail, Brigitte ;
Fouchard-Hubert, Isabelle ;
Gallois, Yves ;
Oberti, Frederic ;
Bertrais, Sandrine ;
Cales, Paul .
HEPATOLOGY, 2013, 57 (03) :1182-1191
[4]   Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C [J].
Castéra, L ;
Vergniol, J ;
Foucher, J ;
Le Bail, B ;
Chanteloup, E ;
Haaser, M ;
Darriet, M ;
Couzigou, P ;
De Lédinghen, V .
GASTROENTEROLOGY, 2005, 128 (02) :343-350
[5]   Non-invasive evaluation of liver fibrosis using transient elastography [J].
Castera, Laurent ;
Forns, Xavier ;
Alberti, Alfredo .
JOURNAL OF HEPATOLOGY, 2008, 48 (05) :835-847
[6]   Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations [J].
Castera, Laurent ;
Foucher, Juliette ;
Bernard, Pierre-Henri ;
Carvalho, Francoise ;
Allaix, Daniele ;
Merrouche, Wassil ;
Couzigou, Patrice ;
de Ledinghen, Victor .
HEPATOLOGY, 2010, 51 (03) :828-835
[7]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[8]   Performance of transient elastography for the staging of liver fibrosis: A meta-analysis [J].
Friedrich-Rust, Mireen ;
Ong, Mei-Fang ;
Martens, Swantje ;
Sarrazin, Christoph ;
Bojunga, Joerg ;
Zeuzem, Stefan ;
Herrmann, Eva .
GASTROENTEROLOGY, 2008, 134 (04) :960-974
[9]  
International Classificiation of Diseases, 2001, CLIN MOD ICD 9 CM
[10]   Risk Assessment of Hepatitis B Virus-Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) [J].
Jung, Kyu Sik ;
Kim, Seung Up ;
Ahn, Sang Hoon ;
Park, Young Nyun ;
Kim, Do Young ;
Park, Jun Yong ;
Chon, Chae Yoon ;
Choi, Eun Hee ;
Han, Kwang-Hyub .
HEPATOLOGY, 2011, 53 (03) :885-894